Divi's Laboratories Ltd to Hold Board Meeting to Review Q1 Financial Results for 2026
Divi's Laboratories Limited announced that its Board of Directors will convene a meeting on Saturday, August 01, 2026. The meeting is scheduled to review and approve the unaudited standalone and consolidated financial results of the company for the quarter that ended June 30, 2026.The upcoming board meeting is set to consider the performance metrics and financial outcomes of Divi's Laboratories for the recently concluded quarter.
In terms of market activity, the trading window for the securities of Divi's Laboratories has been closed since July 01, 2026. The restricted period will remain closed until August 03, 2026, following the declaration of the financial results for the quarter ended June 30, 2026.
DIVISLAB Stock Price Movement
Shares of Divi's Laboratories Limited slipped by 0.82% on Friday to settle at ₹7247.5, declining by ₹60.00 from the previous close. The stock saw heavy volume with 455,060 shares traded, maintaining a tight intraday range between ₹7200 and ₹7316 in pursuit of its 52-week high marked at ₹7390.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.